FLT3LG and melanoma: In this study, we report the design of an FLT3L-encoding oncolytic HSV1 that is capable of inhibiting the growth of melanoma, glioblastoma, and pancreatic adenocarcinoma cell lines and accompanied by the secretion of FLT3L.